CYCN
NASDAQ · Biotechnology
Cyclerion Therapeutics Inc
$1.10
+0.02 (+1.85%)
Open$1.11
Previous Close$1.08
Day High$1.12
Day Low$1.06
52W High$24.43
52W Low$14.23
Volume—
Avg Volume722.6K
Market Cap4.32M
P/E Ratio—
EPS$-1.42
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,879.1% upside
Current
$1.10
$1.10
Target
$21.77
$21.77
$14.42
$21.77 avg
$30.48
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.25M | 1.11M | 1.23M |
| Net Income | -199,437 | -131,808 | -179,754 |
| Profit Margin | -15.9% | -11.8% | -14.7% |
| EBITDA | -171,643 | -161,572 | -173,205 |
| Free Cash Flow | -146,884 | -153,109 | -131,610 |
| Rev Growth | +24.3% | +14.6% | +14.0% |
| Debt/Equity | 0.60 | 0.60 | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |